New hope for Hard-to-Treat blood cancers?
NCT ID NCT04401020
First seen May 08, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This early-stage study tests a new drug called SAR442257 in people with multiple myeloma or non-Hodgkin lymphoma that has come back or stopped responding to other treatments. The main goals are to find a safe dose and check for side effects. About 47 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASM MALIGNANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Site Number : 8400001
Duarte, California, 91010, United States
-
Investigational Site Number : 2030001
Ostrava - Poruba, 70852, Czechia
-
Investigational Site Number : 2030002
Prague, 12808, Czechia
-
Investigational Site Number : 2030003
Brno, 62500, Czechia
-
Investigational Site Number : 4100001
Seoul, Seoul-teukbyeolsi, 03080, South Korea
-
Investigational Site Number : 4100002
Seoul, Seoul-teukbyeolsi, 06351, South Korea
-
Investigational Site Number : 5780001
Oslo, 0440, Norway
-
Investigational Site Number : 5780101
Oslo, 0450, Norway
-
Investigational Site Number : 7240001
Pamplona, Navarre, 31008, Spain
-
Investigational Site Number : 7240003
Badalona, Catalunya [Cataluña], 08916, Spain
-
Investigational Site Number : 7240004
Valencia, 46026, Spain
-
Investigational Site Number : 7240005
Santander, Cantabria, 39008, Spain
-
Investigational Site Number : 7240006
Madrid, Madrid, Comunidad de, 28027, Spain
-
Investigational Site Number : 7240007
Madrid, 28041, Spain
-
Mayo Clinic of Rochester Site Number : 8400003
Rochester, Minnesota, 55905, United States
-
University of Miami - Sylvester Comprehensive Cancer Center Site Number : 8400005
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.